EUVIMED · CrossrefJournal
Therapeutic Advances in Medical Oncology
ISSN 1758-8359 · SAGE Publications
Latest articles
Plasma metabolomic profiling to predict durable response and survival with afatinib in EGFR-mutated non-small cell lung cancer: A prospective, multicenter, observational biomarker study
From genomics to clinic: Guiding venetoclax-based therapy in AML via molecular determinants and risk models
The evolving management of patients with extensive-stage small cell lung cancer in Switzerland: From regulatory access to bedside
Muscle and tissue radiodensity matter: Automated CT-based body composition analysis predicts survival in hepatocellular carcinoma patients undergoing degradable starch microspheres transarterial chemoembolization (DSM-TACE)
The BCLC-CRAFITY model as a novel efficacy predictor for hepatocellular carcinoma treated with curative radiofrequency ablation followed by adjuvant immunotherapy: A retrospective cohort study
The tumor stroma ratio in stage II and III colon cancer: Prognostic impact and evaluation of predictive value
Comparison of efficacy and safety of GP to PX induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: A Propensity Score–Matched analysis
Atypical response and progression patterns in advanced non-small cell lung cancer receiving immunochemotherapy or chemotherapy: A post hoc analysis of CHOICE-01
Chemotherapy-induced peripheral neuropathy (CIPN): Disease mechanisms, experimental models and emerging prevention strategies
Safety and efficacy of TROP2-directed ADCs in HER2-negative breast cancer: A systematic review and network meta-analysis
A quantitative trigger model to enable personalized adaptive radiotherapy in nasopharyngeal carcinoma
Serum angiopoietin-like protein 4 concentration as a predictive biomarker for immunotherapy response in hepatocellular carcinoma
Real-world outcomes of caucasians with EGFR -mutated non-small-cell lung cancer treated with surgery (EXERPOS-2 GFPC study)
Which ARPI first in chemotherapy-naïve mCRPC? Enzalutamide versus abiraterone: A nationwide real-world study
Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33—REGAL study
Biomarker testing in advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2 negative breast cancer: expert recommendations
Antibody-drug conjugates and beyond in platinum-resistant ovarian cancer: A comprehensive review of emergent strategies
Systemic therapy for gastroenteropancreatic neuroendocrine neoplasms: current landscape and future directions
Comprehensive genomic landscape of ERBB2 in Chinese GI tumors: mutation-centered landscapes and precision treatment opportunities
Definitive radiotherapy provides comparable survival with lower toxicity compared with concurrent chemoradiotherapy after long-course induction chemoimmunotherapy in unresectable non-small-cell lung cancer
Induction chemotherapy administration increases the risk of radiation pneumonitis in unresectable stage III NSCLC patients undergoing concurrent chemoradiotherapy with immunotherapy
Antibody-drug conjugates in prostate cancer: current landscape and future directions
Detection of actionable mutations in the cerebrospinal fluid and concordance/discordance with extracranial mutations in patients with metastatic breast cancer and leptomeningeal disease
Molecular complete response to the RIN protocol (regorafenib, ipilimumab, and nivolumab) in a patient with advanced recurrent metastatic mismatch repair proficient/microsatellite stable (pMMR/MSS) rectal cancer
Metabolic marker profiling of circulating tumour cells in NSCLC patients treated with osimertinib: focus on MCT1 and MCT4
Immunotherapy advances in pleural mesothelioma
Cancer-derived inflammation is associated with bevacizumab resistance and inferior clinical outcomes in patients with metastatic colorectal cancer
Gut microbiota and neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a review of current evidence and emerging insights
Efficacy and safety of induction chemoimmunotherapy in older patients with unresectable stage III NSCLC: a real-world multicenter study
Predictive and prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a real-world study from Vietnam
EUVIMED